Acupuncture for the Treatment of Insomnia

Status Completed

Clinical Trial Summary

Insomnia is a common and disabling condition associated with psychiatric and medical comorbidities and often persists despite currently available treatments. Acupuncture has been reported to benefit individuals with insomnia and can decrease hyperarousal. This blinded RCT will investigate the impact of a standardized acupuncture protocol on insomnia, daytime symptoms, and hyperarousal.

Clinical Trial Description

Insomnia is a common problem that is disabling and that frequently persists despite available medical and behavioral approaches. It is associated significant psychiatric and medical comorbidities and high medical and societal costs. Benzodiazepine receptor agonists (BzRA's) and cognitive behavioral therapies are common treatments, but despite these, insomnia remains a pervasive problem. Complementary and alternative medicine (CAM) treatments are being used widely for the treatment of insomnia, but many of these modalities have sparse research support. There are numerous reports in the Traditional Chinese Medicine (TCM)literature of dramatic benefits of acupuncture for the treatment of insomnia, but carefully designed studies are limited. Insomnia has been associated with hyperarousal and acupuncture has documented effects on autonomics with a shift towards parasympathetic predominance. In consultation with experts in acupuncture and TCM, we developed a protocol for the treatment of insomnia and have used it clinically with good success.

We will be conducting a 3-year exploratory pilot randomized-controlled blinded trial (RCT) of this protocol on 56 adults with insomnia disorder, utilizing a control condition involving placement of placebo needles. We seek to determine the effect size of this acupuncture intervention in comparison to the control condition in preparation for a more definitive study, with the future primary aim to determine if acupuncture is effective and well tolerated in the treatment of insomnia. Measures will include self-report and objective measures of sleep quality and duration including polysomnography (PSG). Secondary-exploratory aims will be to determine the impact of this acupuncture protocol on daytime symptoms of insomnia such as fatigue, anxiety, and depression as well as to explore the impact of acupuncture on self-report and objective measures of hyperarousal. ;

Study Design

Related Conditions & MeSH terms

Primary Insomnia
Sleep Initiation and Maintenance Disorders

Clinical Trial Details

NCT number	NCT00855140
Study type	Interventional
Source	University of Pittsburgh
Contact
Status	Completed
Phase	N/A
Start date	March 2009
Completion date	February 2013

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03461666` - Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia	N/A
Recruiting	`NCT02243501` - Better Nights, Better Days for Typically Developing Children	N/A
Completed	`NCT01636791` - CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care	Phase 3
Completed	`NCT00770510` - A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)	Phase 2/Phase 3
Completed	`NCT00520832` - A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys	Phase 2
Recruiting	`NCT00415714` - Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia	N/A
Terminated	`NCT00420810` - Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)	Phase 3
Completed	`NCT00178048` - Paroxetine in the Treatment of Chronic Primary Insomnia	Phase 4
Completed	`NCT00816673` - Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs	Phase 2
Completed	`NCT01960452` - A High Density EEG Comparison of Sleep Patterns in Insomnia	N/A
Completed	`NCT01957111` - Metabolomics of Insomnia-Related Hyperarousal	N/A
Completed	`NCT01181232` - A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients	Phase 4
Completed	`NCT00784875` - An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia	Phase 2
Completed	`NCT00551148` - A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia	Phase 2
Completed	`NCT00397189` - Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients	Phase 3
Completed	`NCT00352144` - 6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia	Phase 3
Completed	`NCT02290405` - Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
Completed	`NCT03314441` - Effects of Regular Practice of Yoga on Subjective and Objective Sleep Quality in Primary Insomnia	N/A
Completed	`NCT00792298` - Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)	Phase 2
Completed	`NCT01021852` - Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.